Ticker · CUSIP 146229109
Holders (tracked)
13
Combined shares
3,957,544
Combined value
$128.25M
Last close
$38.51
Quarter
2025Q4
Price · 1Y$38.51+3.32 (+9.43%)H $44.05 · L $23.07 · Avg Vol 1.4M
Tracked holders · last 8 quarters
-3 vs previous quarter over the last 8.
Price is +18.8% vs the avg quarter-end implied price across tracked holders.
SEC event timeline
25 events
- Ken Griffin (Citadel Advisors) added2026-02-17+397,081 shares · 2025Q4Position
- D.E. Shaw & Co. trimmed2026-02-17−132,727 shares · 2025Q4Position
- Two Sigma Investments trimmed2026-02-17−191,008 shares · 2025Q4Position
- Izzy Englander (Millennium Mgmt) added2026-02-17+40,435 shares · 2025Q4Position
- Steve Cohen (Point72) added2026-02-17+89,846 shares · 2025Q4Position
- T. Rowe Price trimmed2026-02-17−1,837 shares · 2025Q4Position
- Wellington Management added2026-02-17+198,315 shares · 2025Q4Position
- Jeremy Grantham (GMO) added2026-02-17+1,040 shares · 2025Q4Position
- Bill Nygren (Harris / Oakmark) exited2026-02-17−11,700 shares · 2025Q4Position
- AQR Capital Management trimmed2026-02-17−153,964 shares · 2025Q4Position
- Lee Ainslie (Maverick Capital) added2026-02-13+24,535 shares · 2025Q4Position
- Renaissance Technologies exited2026-02-12−76,500 shares · 2025Q4Position
- −89,734 shares · 2025Q3Position
- Izzy Englander (Millennium Mgmt) added2025-11-14+337,880 shares · 2025Q3Position
- Wellington Management trimmed2025-11-14−2,435 shares · 2025Q3Position
- Two Sigma Investments added2025-11-14+279,267 shares · 2025Q3Position
- D.E. Shaw & Co. trimmed2025-11-14−539,322 shares · 2025Q3Position
- AQR Capital Management trimmed2025-11-14−1,997,021 shares · 2025Q3Position
- Bill Nygren (Harris / Oakmark) trimmed2025-11-14−2,170 shares · 2025Q3Position
- Steve Cohen (Point72) opened position2025-11-14+73,296 shares · 2025Q3Position
- +124,255 shares · 2025Q3Position
- T. Rowe Price added2025-11-14+1,669 shares · 2025Q3Position
- Jeremy Grantham (GMO) trimmed2025-11-13−3,899 shares · 2025Q3Position
- Renaissance Technologies trimmed2025-11-13−155,200 shares · 2025Q3Position
- Norges Bank (Norway SWF) exited2025-11-12−179,353 shares · 2024Q3Position
Insider activity
No insider transactions in the last 30 days.
Follow-the-investor returns
If you'd copied each holder of CRI…
Cost basis inferred from each manager's quarter-over-quarter position changes. Sorted by % return on the position they're still holding.
| Investor | First in | Cost basis | Return | Position value today |
|---|---|---|---|---|
| Ken Griffin (Citadel Advisors) | 2016Q1 | $32.38 | +18.9% | $1.7M |
| Ken Griffin (Citadel Advisors) | 2016Q1 | $32.38 | +18.9% | $1.7M |
| Ken Griffin (Citadel Advisors) | 2016Q1 | $32.38 | +18.9% | $1.7M |
| D.E. Shaw & Co. | 2016Q1 | $32.40 | +18.8% | $39.7M |
| D.E. Shaw & Co. | 2016Q1 | $32.40 | +18.8% | $39.7M |
| Two Sigma Investments | 2016Q1 | $33.71 | +14.2% | $7.3M |
| Izzy Englander (Millennium Mgmt) | 2016Q1 | $34.39 | +12.0% | $27.0M |
| Lee Ainslie (Maverick Capital) | 2016Q1 | $43.92 | -12.3% | $5.7M |
| AQR Capital Management | 2016Q1 | $44.34 | -13.2% | $15.9M |
| Steve Cohen (Point72) | 2016Q1 | $48.19 | -20.1% | $6.3M |
| Wellington Management | 2016Q1 | $49.04 | -21.5% | $23.4M |
| T. Rowe Price | 2016Q1 | $71.53 | -46.2% | $1.3M |
| Jeremy Grantham (GMO) | 2018Q2 | $81.50 | -52.7% | $520K |
Who moved on this name in 2025Q4
Position changes reported for the latest quarter, grouped by direction.
New positions0
—
Added to6
- Ken Griffin (Citadel Advisors)+397,081$12.9M
- Wellington Management+198,315$6.4M
- Steve Cohen (Point72)+89,846$2.9M
- Izzy Englander (Millennium Mgmt)+40,435$1.3M
- Lee Ainslie (Maverick Capital)+24,535$796K
- Jeremy Grantham (GMO)+1,040$34K
Trimmed4
- Two Sigma Investments−191,008$6.2M
- AQR Capital Management−153,964$5.0M
- D.E. Shaw & Co.−132,727$4.3M
- T. Rowe Price−1,837$60
Exited2
- Renaissance Technologies−76,500$2.2M
- Bill Nygren (Harris / Oakmark)−11,700$330K
Institutional ownership over time
Distinct super-investors holding this ticker · combined dollar value, by quarter.
| Quarter | Holders | Combined value |
|---|---|---|
| 2022Q1 | 14 | $33.90B |
| 2022Q2 | 11 | $23.30B |
| 2022Q3 | 12 | $548.8M |
| 2022Q4 | 11 | $569.0M |
| 2023Q1 | 15 | $575.0M |
| 2023Q2 | 14 | $577.3M |
| 2023Q3 | 13 | $414.6M |
| 2023Q4 | 13 | $472.7M |
| 2024Q1 | 15 | $625.5M |
| 2024Q2 | 12 | $465.2M |
| 2024Q3 | 14 | $270.1M |
| 2024Q4 | 12 | $208.9M |
| 2025Q1 | 15 | $222.3M |
| 2025Q2 | 15 | $177.8M |
| 2025Q3 | 16 | $109.6M |
| 2025Q4 | 13 | $128.2M |
Who owns CRI
13 super-investors · 2025Q4
Tracked stake
3.96M
shares
Combined value
$128M
% of shares outstanding
—
shares-out unknown
Quarter action mix
Added8Trim5
| # | Manager | Shares | Value |
|---|---|---|---|
| 1 | D.E. Shaw & Co. | 1.03M | $33M |
| 2 | Izzy Englander Millennium Mgmt | 702.4K | $23M |
| 3 | Wellington Management | 608.1K | $20M |
| 4 | Ken Griffin Citadel Advisors | 592.8K | $19M |
| 5 | AQR Capital Management | 413.5K | $13M |
| 6 | Two Sigma Investments | 189.3K | $6M |
| 7 | Steve Cohen Point72 | 163.1K | $5M |
| 8 | Lee Ainslie Maverick Capital | 148.8K | $5M |
| 9 | Ken Griffin Citadel Advisors | 43.4K | $1M |
| 10 | T. Rowe Price | 34.8K | $1M |
| 11 | Jeremy Grantham GMO | 13.5K | $438K |
| 12 | Ken Griffin Citadel Advisors | 9.0K | $292K |
| 13 | D.E. Shaw & Co. | 7.0K | $227K |
Recent moves
20 transactions
- +1,040 · 2025Q4
- +89,846 · 2025Q4
- −11,700 · 2025Q4
- TRIMT. Rowe Price−1,837 · 2025Q4
- +40,435 · 2025Q4
- +397,081 · 2025Q4
- TRIMD.E. Shaw & Co.−132,727 · 2025Q4
- −153,964 · 2025Q4
- −191,008 · 2025Q4
- +198,315 · 2025Q4
- +24,535 · 2025Q4
- −76,500 · 2025Q4
- −89,734 · 2025Q3
- +73,296 · 2025Q3
- +124,255 · 2025Q3
- +279,267 · 2025Q3
- TRIMD.E. Shaw & Co.−539,322 · 2025Q3
- +337,880 · 2025Q3
- +1,669 · 2025Q3
- −2,435 · 2025Q3
Embed this chart
Paste this iframe anywhere to embed the live CRI chart.
<iframe src="https://openstocks.me/embed/stocks/CRI" width="100%" height="480" frameborder="0" loading="lazy" title="CRI chart by OpenStocks" style="border:0;border-radius:12px;background:transparent"></iframe>Explore related topics
- CRI insider tradingEvery Form 4 filing by CRI officers, directors, and 10%+ holders.
- CRI analyst target pricesWall Street consensus target, analyst-by-analyst breakdown, and revision history.
- Most popular hedge-fund stocksSee where this ticker ranks against the broader smart-money consensus.
- All insider tradingCross-ticker view of where corporate insiders are buying on the open market.
- Congress stock tradesReal-time PTR disclosures filed under the STOCK Act.
- Smart-money signalsComposite signals where institutional, insider and Congress flows converge.